4
Changes in Ownership
GENELUX Corp Filed Acc 0001209191-23-057975
VP, Clinical Trial Operations sold 36,800 shares at $11.85 ($435,995)
From the SEC's structured data for this filing
Trades in this filing
Yu Yong · VP, Clinical Trial Operations
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-07 | Sale : show line 1 in the form | −36,800 | $11.85 | $435,995 | 32,535 | D |
| Open-market sales · 36,800 sh · avg $11.85 · $435,995 | ||||||
Loading xslF345X05/doc4.xml…